Allergan (AGN), Editas Medicine (EDIT) Enter Alliance to Discover and Develop CRISPR Genome Editing Medicines … – StreetInsider.com
|
Allergan (AGN), Editas Medicine (EDIT) Enter Alliance to Discover and Develop CRISPR Genome Editing Medicines …
StreetInsider.com The agreement covers early stage, first-in-class ocular programs targeting serious diseases based on Editas Medicine’s unparalleled CRISPR genome editing platform, including CRISPR/Cas9 and CRISPR/Cpf1. Editas Medicine’s lead program is being … |
MedCity News |
Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing …
GlobeNewswire (press release) The agreement covers early stage, first-in-class ocular programs targeting serious diseases based on Editas Medicine’s unparalleled CRISPR genome editing platform, including CRISPR/Cas9 and CRISPR/Cpf1. Editas Medicine’s lead program is being … Allergan and Editas announce $90M CRISPR dealMedCity News Editas, Allergan Ink $90M CRISPR-Based Eye Drug DealGenomeWeb Allergan makes a deal with Editas to License CRISPR Programs for Eye DiseaseLabiotech.eu (blog) |
|
BRIEF-Crispr and Casebia announce commercial license agreement with Maxcyte
Reuters March 14 Stock futures pointed to a lower opening for Canada’s main stock index on Tuesday as investors awaited the start of the two-day U.S. Federal Reserve meeting, even as oil prices recovered modestly from three-month lows. March futures on the S&P … |
Labiotech.eu (blog) |
The First 3D DNA Structure could advance Stem Cell Therapies
Labiotech.eu (blog) For the first time, researchers from the University of Cambridge were able to determine the 3D structure of the genome of mouse embryonic stem cells. Tim Stevens and his colleagues used a combination of imaging and measurements that reveal DNA … Here’s the first 3D glimpse of how DNA is packaged up in a single cellArs Technica Visualizing the genome: First 3-D structures of active DNA createdScience Daily Mapping the Genome in 3DTechnology Networks |
Business Weekly |
The First 3D Structure of Active DNA could advance Stem Cell Therapies
Labiotech.eu (blog) For the first time, researchers from the University of Cambridge were able to determine the 3D structure of an active mouse genome in embryonic stem cells. Tim Stevens and his colleagues used a combination of imaging and measurements that reveal DNA … Here’s the first 3D glimpse of how DNA is packaged up in a single cellArs Technica Visualizing the genome: First 3-D structures of active DNA created …Science Daily First 3D structures of active DNA createdIndia Today Cambridge News –Technology Networks all 8 news articles » |
Proactive Investors UK |
CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte
Yahoo Finance Under the terms of the license, CRISPR Therapeutics and Casebia will obtain non-exclusive commercial-use rights to MaxCyte’s cell engineering platform to develop CRISPR/Cas9-based therapies for hemoglobin-related diseases and severe combined … MaxCyte Inks License Deal With CRISPR Therapeutics And BayerLondon South East (registration) (blog) MaxCyte deal puts it at the forefront of developments in the cutting edge arena of gene editingProactive Investors UK |
DIGITALLOOK |
CRISPR Therapeutics and Casebia Therapeutics Announce …
GlobeNewswire (press release) CRISPR Therapeutics and Casebia obtain commercial rights to MaxCyte’s cell engineering platform to develop CRISPR/Cas9-based therapies. CRISPR Therapeutics Licenses Cell Engineering Platform From MaxCyteGenomeWeb CRISPR & Bayer acquire license to cell engineering technologyThe Pharma Letter (registration) MaxCyte signs cell platform deal with CRISPR and CasebiaDIGITALLOOK |